SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001104659-22-022651
Filing Date
2022-02-14
Accepted
2022-02-14 16:02:15
Documents
1
Group Members
HENRY A. PLAIN, JR.JASON W. LETTMANNJEAN M. GEORGELIGHTSTONE VENTURES II(A), L.P.LIGHTSTONE VENTURES II, L.P.LSV ASSOCIATES II, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G tm226605d1_sc13g.htm SC 13G 130702
  Complete submission text file 0001104659-22-022651.txt   132454
Mailing Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421
Business Address 128 SPRING STREET BUILDING A, SUITE 510 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Subject) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92616 | Film No.: 22631178
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 BOYLSTON STREET, SUITE 1380 BOSTON MA 02116
Business Address 500 BOYLSTON STREET, SUITE 1380 BOSTON MA 02116 (617) 850 - 9700
Lightstone Ventures II, L.P. (Filed by) CIK: 0001699565 (see all company filings)

IRS No.: 820626297 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G